Latest Articles
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - Business Wire
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer Business Wire
Published: Oct. 20, 2025, noon
Endometriosis vs Fibroids: What to Know - HealthCentral
Endometriosis vs Fibroids: What to Know HealthCentral
Published: Oct. 20, 2025, 11:58 a.m.
Scientists develop breakthrough approach to detecting endometriosis in menstrual blood - FemTech World
Scientists develop breakthrough approach to detecting endometriosis in menstrual blood FemTech World
Published: Oct. 20, 2025, 11:36 a.m.
Cyclana Bio raises £5 million to advance novel endometriosis therapies - The Pharma Letter
Cyclana Bio raises £5 million to advance novel endometriosis therapies The Pharma Letter
Published: Oct. 20, 2025, 11:08 a.m.
What do you think of the new endometriosis care plan? - Newstalk
What do you think of the new endometriosis care plan? Newstalk
Published: Oct. 20, 2025, 11 a.m.
Cyclana Bio Raises £5M to Advance Drug Discovery for Endometriosis - Business Wire
Cyclana Bio Raises £5M to Advance Drug Discovery for Endometriosis Business Wire
Published: Oct. 20, 2025, 10:40 a.m.
Cyclana Bio Raises £5M To Advance Drug Discovery for Endometriosis - Technology Networks
Cyclana Bio Raises £5M To Advance Drug Discovery for Endometriosis Technology Networks
Published: Oct. 20, 2025, 10:32 a.m.
Health Minister apologises to women and girls for years of endometriosis neglect - rollercoaster.ie
Health Minister apologises to women and girls for years of endometriosis neglect rollercoaster.ie
Published: Oct. 20, 2025, 9:53 a.m.
Shifted assembly and function of mSWI/SNF family subcomplexes underlie targetable dependencies in dedifferentiated endometrial carcinomas - Nature
Shifted assembly and function of mSWI/SNF family subcomplexes underlie targetable dependencies in dedifferentiated endometrial carcinomas Nature
Published: Oct. 20, 2025, 9:19 a.m.
Cyclana Bio Raises £5M to Reverse Endometriosis Through Extracellular Matrix Targeting - Femtech Insider
Cyclana Bio Raises £5M to Reverse Endometriosis Through Extracellular Matrix Targeting Femtech Insider
Published: Oct. 20, 2025, 8:02 a.m.
Link copied to clipboard!